Rapid cell-free characterization of multi-subunit CRISPR effectors and transposons
Franziska Wimmer1, Ioannis Mougiakos1, Frank Englert1
1Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97080 Würzburg, Germany.
Molecular Cell
|February 26, 2022
Summary
Cell-free systems accelerate CRISPR research by enabling rapid characterization of complex, multi-subunit CRISPR-Cas effectors and transposons. This breakthrough simplifies studying diverse biological systems and their applications.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- CRISPR-Cas research has primarily focused on single-effector nucleases.
- Multi-subunit CRISPR effectors are prevalent in nature and emerging technologies, but challenging to study.
- Understanding these complex systems is crucial for harnessing their full potential.
Purpose of the Study:
- To develop a rapid method for characterizing multi-subunit CRISPR effectors and transposons.
- To overcome the challenges associated with in vitro and in vivo manipulation of multi-subunit complexes.
- To explore the diversity and function of understudied CRISPR-Cas systems.
Main Methods:
- Application of cell-free transcription-translation (TXTL) systems.
- Simultaneous combination of multiple DNA constructs in a single TXTL reaction.
- Analysis of biomolecular readouts within hours.
Main Results:
- Rapid characterization of phylogenetically diverse I-E CRISPR effectors.
- Elucidation of targeting rules for I-B and I-F CRISPR transposons using DNA-binding components.
- Recapitulation of DNA transposition in TXTL, revealing a novel branch of I-B CRISPR transposons.
Conclusions:
- TXTL systems provide a powerful and accelerated approach to studying complex CRISPR-Cas effectors and transposons.
- This methodology facilitates the investigation of diverse and previously underexplored CRISPR systems.
- The findings pave the way for broader exploitation of CRISPR-Cas diversity in biotechnology and research.
Related Concept Videos
CRISPR/Cas9 Genome Editing
526
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
526
CRISPR
53.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.3K
CRISPR and crRNAs
17.6K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.6K


